The study by Peng-Lin Guan published in Nature Communications uncovers a surprising connection between our genes, our gut microbes, and our bone health. This study centered at the Laboratory of Precision Health and Data Science at the University Suzhou, China, shows that a few specific gut bacteria, especially Bifidobacterium adolescentis and its close relatives, are shaped by genetic factors and can in fact contribute to lower bone mineral density. By integrating very large genetic datasets, they trace this link to the well-known lactose tolerance region in our genome and to a circulating fatty acid called stearidonate, which accounts for most of the bacteria’s effect on bone. People with lactose intolerance genotypes tend to harbor more of these microbes, which increases stearidonate levels and may ultimately weaken bone strength. This helps explain why some individuals lose bone more readily even when their diet looks similar to others.
In everyday life, this means that something as routine as how well we digest milk can shape which microbes thrive in our gut and how those microbes influence our skeleton. Bone health emerges not only from nutrition and hormones but also from a quiet genetic and microbial partnership that has evolved over generations. What is new here is the clear, data-driven chain linking genetics, gut bacteria, and metabolites to measurable differences in bone density. Previous studies hinted at a gut–bone relationship, but this work identifies a specific mechanism and provides strong evidence using modern genetic tools.
The study raises whether dietary interventions, probiotics, or omega-3 fatty acids counteract this microbial pathway in people who are genetically prone to lactose intolerance. And can tailoring nutrition to an individual’s genetic and microbial profile meaningfully protect long-term bone health.
Read the original article here.